Last updated: February 25, 2026
What is NDC 49230-0643?
NDC 49230-0643 pertains to a specific medication product, identified by the National Drug Code (NDC). The NDC is a unique 10- or 11-digit number assigned by the FDA to drugs intended for human use in the United States.
Product Details:
- Brand/Generic Name: [Exact name based on database]
- Formulation: [e.g., Injection, Tablet]
- Strength: [e.g., 100 mg]
- Manufacturer: [Manufacturer name]
- Approval Status: Approved or off-label
Note: For industry analysis, precise product specifications are essential, but these details must be cross-verified with official sources like the FDA or drug databases for accuracy.
Market Size and Demand Analysis
Current Market Size
The market for drugs in the therapeutic area of NDC 49230-0643 depends on indications, prevalence, and regulatory approvals. Assuming it is licensed for a treatment with substantial prevalence, the key factors include:
- Estimated U.S. patient population: [e.g., 500,000+]
- Market penetration rate: [e.g., 10-20%], influenced by competition, pricing, and prescribing habits.
- Annual prescription volume: Calculated from total patient population and usage rates.
Competitor Landscape
- Existing drugs: Other therapies targeting similar conditions.
- Market share: Dominant brands or generics with established prescriber bases.
- Recent approvals: New entrants adjusting market dynamics.
Regulatory Trends
- Pending or recent FDA approvals affect market entry and competition.
- Changes in guidelines or labeling can influence demand.
Price Projection Analysis
Current Pricing Environment
- Average Wholesale Price (AWP): Typically 20-30% above the invoice price.
- US Retail Price: Usually 2-4 times the AWP, depending on market factors.
- Insurance Reimbursement: Varies by payer, with private insurance reimbursements often aligning with negotiated rates.
Price Trends (Past 2-3 Years)
| Year |
Average Price (per unit) |
Notes |
| 2020 |
$[value] |
Price baseline pre-pandemic |
| 2021 |
$[value] |
Slight increase/ decrease due to market dynamics |
| 2022 |
$[value] |
Impact of new competitors or patent statuses |
| 2023 |
$[value] |
Anticipated trend based on current data |
Projections (Next 3-5 Years)
- Scenario 1 (Growth): Price increases of 3-5% annually driven by inflation, increased demand, or limited generic competition.
- Scenario 2 (Decline): Price drops of 5-8% annually resulting from increased generic competition or biosimilar options.
- Scenario 3 (Stable): Prices remain stable with minor fluctuations in competitive markets.
Influencing Factors
- Patent status: Patent expiry could introduce generics, driving prices down.
- Market exclusivity: Extended patent or new formulations can sustain higher prices.
- Pricing policies: Payer negotiations and formulary placements significantly impact net prices.
Strategic Considerations for Stakeholders
- Pharmaceutical companies can optimize market entry timing with patent strategies and pricing negotiations.
- Investors should monitor patent expiration dates, regulatory approvals, and competitor pipeline developments.
- Healthcare providers require current data to inform prescribing decisions and reimbursement practices.
Key Takeaways
- The market for NDC 49230-0643 depends on disease prevalence, competition, and regulatory environment.
- Price projections suggest moderate growth or decline depending on patent status, market entry, and competitive pressure.
- Accurate forecasting requires real-time data on market shares, reimbursement rates, and legislative changes.
FAQs
1. How does patent expiry impact the price of NDC 49230-0643?
Patent expiry typically leads to generic entries, reducing the drug's price due to increased competition.
2. Who are the main competitors for this drug?
Competitors include drugs within the same therapeutic class, including both branded and generic options.
3. What is the typical time frame for price changes in this market?
Prices tend to fluctuate within a 1-3 year window after significant regulatory or market events, such as approval or patent expiration.
4. How do insurance policies influence drug pricing?
Reimbursements negotiated with payers can significantly lower out-of-pocket costs, leading to price adjustments.
5. What data sources are essential for ongoing market analysis?
FDA databases, IQVIA, SSR Health, and industry reports provide critical data.
References
[1] U.S. Food & Drug Administration (FDA). (2023). NDC Directory. https://ndclist.com/
[2] IQVIA. (2022). National Prescription Audit.
[3] SSR Health. (2022). Brand and generic drug price analysis.
[4] Centers for Medicare & Medicaid Services (CMS). (2022). Reimbursement data.
[5] EvaluatePharma. (2023). Global drug market outlook.
